-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, IVh+yIQ8NBP1r1rSrvH1EvBfovw/IYFgPazljNq8nrRptROfDfPnTfYNlXcCDQOR bdMtTrMQYGlT2+cWpJm8Dg== 0000950159-07-000711.txt : 20070515 0000950159-07-000711.hdr.sgml : 20070515 20070515160408 ACCESSION NUMBER: 0000950159-07-000711 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070331 FILED AS OF DATE: 20070515 DATE AS OF CHANGE: 20070515 EFFECTIVENESS DATE: 20070515 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DEERFIELD MANAGEMENT CO /NY CENTRAL INDEX KEY: 0001009258 IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-05366 FILM NUMBER: 07853206 BUSINESS ADDRESS: STREET 1: 780 THIRD AVENUE STREET 2: 37TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 2125511600 MAIL ADDRESS: STREET 1: 780 THIRD AVENUE, 37TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 13F-HR 1 deerfld13f.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 13F FORM 13F COVER PAGE Report for the Calendar Year or Quarter Ended: March 31, 2007 Check here if Amendment [ ]; Amendment Number: This Amendment (Check only one.): [ ] is a restatement. [ ] adds new holdings entries. Institutional Investment Manager Filing this Report: Name: Deerfield Management Company, LP Address: 780 Third Avenue, 37th Floor New York, NY 10017 Form 13F File Number: 28-5366 The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: Flynn Management LLC, its general partner Name: James E. Flynn Title: Managing Member Phone: 212-551-1600 Signature, Place, and Date of Signing: /s/ James E. Flynn New York, NY 05/15/07 - ------------------ ------------ -------- [Signature] [City, State] [Date] Report Type (Check only one.): [X] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.) [ ] 13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).) [ ] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager is reported in this report and a portion is reported by other reporting manager(s).)
TITLE OF VALUE SHARES/ SH/ PUT/ INVSTMT OTHER VOTING AUTHORITY NAME OF ISSUER CLASS CUSIP x($1000) PRN AMT PRN CALL DISCRETN MANAGERS SOLE SHARED NONE - ---------------------------------------------------------------------------------------------------------------------------------- ACCURAY INC COM 004397105 13,010 585,000 SH DEFINED 01 585,000 ADVANCIS PHARMACEUTI CAL CORP COM 00764L109 7,861 3,573,002 SH DEFINED 01 3,573,002 ALLION HEALTHCARE INC COM 019615103 1,175 287,200 SH DEFINED 01 287,200 ALTUS PHARMACEUTICALS INC COM 02216N105 837 55,011 SH DEFINED 01 55,011 AMEDISYS INC COM 23436108 7,994 246,490 SH DEFINED 01 246,490 AMERICAN MEDICAL SYSTEMS HOLD COM 02744M108 49,013 2,315,200 SH DEFINED 01 2,315,200 AMERISOURCE HEALTH CORP COM 03073E105 10,550 200,000 SH DEFINED 01 200,000 AMGEN INC COM 031162100 3,575 63,977 SH DEFINED 01 63,977 AMICAS INC COM 001712108 4,477 1,576,504 SH DEFINED 01 1,576,504 AMYLIN PHARMACEUTICALS INC COM 032346108 4,670 125,000 SH DEFINED 01 125,000 ANADYS PHARMACEUTICALS INC COM 03252Q408 11,315 2,850,000 SH DEFINED 01 2,850,000 ANIMAL HEALTH INTL INC COM 03525N109 2,720 225,000 SH DEFINED 01 225,000 AP PHARMA INC COM 00202J104 675 650,000 SH DEFINED 01 650,000 APRIA HEALTHCARE GROUP INC COM 037933108 16,125 500,000 PUT DEFINED 01 500,000 ARADIGM CORP COM 038505301 3,672 3,010,000 SH DEFINED 01 3,010,000 ARENA PHARMACEUTICALS COM 040047102 43,440 4,000,000 SH DEFINED 01 4,000,000 ARRAY BIOPHARMA INC COM 04269X105 40,111 3,158,360 SH DEFINED 01 3,158,360 ATS MED INC COM 002083103 3,984 1,934,200 SH DEFINED 01 1,934,200 BIOVAIL CORP COM 09067J109 87,683 4,011,100 SH DEFINED 01 4,011,100 BIOVAIL CORP COM 09067J109 26,232 1,200,000 CALL DEFINED 01 1,200,000 CAPITAL SR LIVING CORP COM 140475104 9,307 801,600 SH DEFINED 01 801,600 CARDINAL HEALTH INC COM 14149Y108 45,690 626,323 SH DEFINED 01 626,323 CAS MEDICAL SYSTEMS INC COM 124769209 2,169 310,293 SH DEFINED 01 310,293 CELGENE CORP COM 151020104 54,155 1,032,302 SH DEFINED 01 1,032,302 CEPHALON INC COM 156708109 30,468 427,858 SH DEFINED 01 427,858 CIGNA CORP COM 125509109 58,205 408,000 SH DEFINED 01 408,000 COLEY PHARMACEUTICAL GROUP I COM 19388P106 2,969 309,874 SH DEFINED 01 309,874 COLLAGENEX PHARMACEUTICALS I COM 19419B100 22,967 1,700,000 SH DEFINED 01 1,700,000 CUBIST PHARMACEUTICALS INC COM 229678107 54,703 2,478,634 SH DEFINED 01 2,478,634 CVS CAREMARK CORP COM 126650100 41,822 1,225,000 SH DEFINED 01 1,225,000 CYCLACEL PHARMACEUTICALS INC COM 23254L108 11,404 1,471,429 SH DEFINED 01 1,471,429 CYPRESS BIOSCIENCE INC COM 232674507 2,394 315,000 CALL DEFINED 01 315,000 DIALYSIS CORP OF AMERICA COM 252529102 4,749 376,000 SH DEFINED 01 376,000 DISCOVERY LABORATORIES INC N COM 254668106 615 259,359 SH DEFINED 01 259,359 DYNAVAX TECHS COM 268158102 26,392 4,851,538 SH DEFINED 01 4,851,538 EMAGEON INC COM 29076V109 19,174 1,743,100 SH DEFINED 01 1,743,100 ENDO PHARMACEUTICALS HLDGS I COM 29264F205 13,122 446,342 SH DEFINED 01 446,342 EXELIXIS INC COM 30161Q104 26,721 2,688,270 SH DEFINED 01 2,688,270 EXPRESS SCRIPTS INC COM 302182100 14,126 175,000 SH DEFINED 01 175,000 FAMILYMEDS GROUP INC COM 30706T209 843 327,937 SH DEFINED 01 327,937 FIVE STAR QUALITY CARE INC COM 33832D106 11,183 1,087,800 SH DEFINED 01 1,087,800 FOX HOLLOW TECHNOLOG IES INC COM 35166A103 20,890 1,000,000 SH DEFINED 01 1,000,000 GENZYME CORP COM 372917104 15,005 250,000 SH DEFINED 01 250,000 HANA BIOSCIENCES INC COM 40963P105 3,138 1,643,188 SH DEFINED 01 1,643,188 HEALTH NET INC COM 42222G108 23,933 444,766 SH DEFINED 01 444,766 HEALTHSPRING INC COM 42224N101 4,202 178,424 SH DEFINED 01 178,424 INFINITY PHARMACEUTICALS INC COM 45665G303 3,484 289,361 SH DEFINED 01 289,361 INSPIRE PHARMACEUTICALS INC COM 457733103 32,258 5,659,285 SH DEFINED 01 5,659,285 INTERMUNE INC COM 45884X103 49,842 2,021,162 SH DEFINED 01 2,021,162 INTRALASE CORP COM 461169104 17,236 690,000 SH DEFINED 01 690,000 ISTA PHARMACEUTICALS INC COM 45031X204 26,110 3,082,620 SH DEFINED 01 3,082,620 KOSAN BIOSCIENCES INC COM 50064W107 4,869 885,200 SH DEFINED 01 885,200 MAGELLAN HEALTH SERVICES INC COM 559079207 21,417 509,936 SH DEFINED 01 509,936 MANNKIND CORP COM 56400P201 12,257 857,143 SH DEFINED 01 857,143 MANNKIND CORP NOTE 3.750% 12/1 56400PAA0 1,485 1,500,000 PRN DEFINED 01 1,500,000 MCKESSON CORP COM 58155Q103 58,540 1,000,000 SH DEFINED 01 1,000,000 MEDAREX INC COM 583916101 1,203 93,000 SH DEFINED 01 93,000 MEDICINES CO COM 584688105 12,791 510,012 SH DEFINED 01 510,012 MEDIMMUNE INC COM 584699102 364 10,000 SH DEFINED 01 10,000 MERCK & CO INC COM 589331107 44,170 1,000,000 SH DEFINED 01 1,000,000 METABASIS THRPTC COM 59101M105 3,765 512,262 SH DEFINED 01 512,262 MGI PHARMA INC COM 552880106 37,833 1,683,701 SH DEFINED 01 1,683,701 NEUROMETRIX INC COM 641255104 1,658 170,711 SH DEFINED 01 170,711 NXSTAGE MEDICAL INC COM 67072V103 17,086 1,282,696 SH DEFINED 01 1,282,696 ONYX PHARMACEUTICALS COM 683399109 18,034 726,000 SH DEFINED 01 726,000 OPTION CARE INC COM 683948103 13,300 1,000,026 SH DEFINED 01 1,000,026 PAR PHARMACEUTICAL COS INC COM 69888P106 74,912 2,982,160 SH DEFINED 01 2,982,160 PONIARD PHARMACEUTICALS INC COM 732449301 10,189 1,787,463 SH DEFINED 01 1,787,463 REPLIDYNE INC COM 76028W107 973 175,000 SH DEFINED 01 175,000 RES-CARE INC COM 760943100 9,518 543,900 SH DEFINED 01 543,900 RESMED INC COM 761152107 27,003 536,100 SH DEFINED 01 536,100 RESPIRONICS INC COM 761230101 70,742 1,684,734 SH DEFINED 01 1,684,734 RIGEL PHARMACEUTICAL S INC COM 766559603 16,600 1,528,520 SH DEFINED 01 1,528,520 ROSETTA GENOMICS LTD COM M82183100 3,395 500,000 SH DEFINED 01 500,000 SEATTLE GENETICS INC COM 812578102 332 40,500 SH DEFINED 01 40,500 SENIOR HSG PPTYS TR SH BEN INT 81721M109 10,755 450,000 SH DEFINED 01 450,000 SEPRACOR INC COM 817315104 39,947 856,680 SH DEFINED 01 856,680 SOMANETICS CORP COM 834445405 14,795 742,000 SH DEFINED 01 742,000 SPECTRANETICS CORP COM 84760C107 22,464 2,099,453 SH DEFINED 01 2,099,453 STAAR SURGICAL CO COM 852312305 4,230 767,746 SH DEFINED 01 767,746 SUNESIS PHARMACEUTICALS INC COM 867328502 7,848 1,744,006 SH DEFINED 01 1,744,006 SUPERGEN INC COM 868059106 14,936 2,531,452 SH DEFINED 01 2,531,452 TENET HEALTHCARE CORP COM 88033G100 6,430 1,000,000 SH DEFINED 01 1,000,000 THE TRIZETTO GROUP INC COM 896882107 8,004 400,000 SH DEFINED 01 400,000 THIRD WAVE TECHNOLOGIES COM 88428W108 25,164 4,934,065 SH DEFINED 01 4,934,065 TUTOGEN MED INC COM 901107102 5,461 650,846 SH DEFINED 01 650,846 VERTEX PHARMACEUTICALS INC COM 92532F100 15,422 550,000 SH DEFINED 01 550,000 VISICU INC COM 92831L204 4,772 611,800 SH DEFINED 01 611,800 WELLPOINT HEALTH NETWORKS INC COM 94973V107 26,706 329,300 SH DEFINED 01 329,300 ZOLL MEDICAL CORP COM 989922109 986 37,000 SH DEFINED 01 37,000 ZYMOGENETICS INC COM 98985T109 23,340 1,500,000 SH DEFINED 01 1,500,000 91 1,682,091
FORM 13F SUMMARY PAGE Report Summary: Number of Other Included Managers: 1 Form 13F Information Table Entry Total: 91 Form 13F Information Table Value Total: $1,682,091 (thousands) List of Other Included Managers: Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report. [If there are no entries in this list, state "NONE" and omit the column headings and list entries.] No. Form 13F File Number Name 01 28-11827 Flynn Management LLC -----END PRIVACY-ENHANCED MESSAGE-----